Ramiro Vazquez

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Targeting histamine H4 receptor improves anti-tumoral response in a murine model of breast cancer.

Targeting histamine H4 receptor improves anti-tumoral response in a murine model of breast cancer.

Journal: Frontiers in immunology

Published: December 18, 2025

Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein.

Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein.

Journal: Cell death discovery

Published: December 21, 2022

Role of the Tyrosine Phosphatase SHP-2 in Mediating Adrenomedullin Proangiogenic Activity in Solid Tumors.

Role of the Tyrosine Phosphatase SHP-2 in Mediating Adrenomedullin Proangiogenic Activity in Solid Tumors.

Journal: Frontiers in oncology

Published: August 04, 2021

Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile.

Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile.

Journal: European journal of medicinal chemistry

Published: July 21, 2021

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.

Journal: Frontiers in oncology

Published: July 30, 2020

Identifying pathophysiological bases of disease in COVID-19.

Identifying pathophysiological bases of disease in COVID-19.

Journal: Translational medicine communications

Published: July 23, 2020

Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models.

Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models.

Journal: Leukemia & lymphoma

Published: June 18, 2019

Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells.

Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells.

Journal: Frontiers in oncology

Published: January 23, 2019

Efficacy of Novel Bromodomain and Extraterminal Inhibitors in Combination with Chemotherapy for Castration-Resistant Prostate Cancer.

Efficacy of Novel Bromodomain and Extraterminal Inhibitors in Combination with Chemotherapy for Castration-Resistant Prostate Cancer.

Journal: European urology oncology

Published: November 20, 2018

Epigenetic Control of Mitochondrial Fission Enables Self-Renewal of Stem-like Tumor Cells in Human Prostate Cancer.

Epigenetic Control of Mitochondrial Fission Enables Self-Renewal of Stem-like Tumor Cells in Human Prostate Cancer.

Journal: Cell metabolism

Published: June 11, 2018

Potential negative effects of anti-histamines on male reproductive function.

Potential negative effects of anti-histamines on male reproductive function.

Journal: Reproduction (Cambridge, England)

Published: November 09, 2017

The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.

The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.

Journal: Oncotarget

Published: July 25, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026